The University of Graz, located in Graz, Austria, is the largest and oldest university in Styria, as well as the second-largest and second-oldest university in Austria.

During the past decade, Karl-Franzens-University Graz conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Karl-Franzens-University Graz" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 8 trials, followed by "Vertex Pharmaceuticals Incorporated" with 3 trials sponsored, "Intercept Pharmaceuticals" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "AqueSys, Inc." with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Karl-Franzens-University Graz" #1 collaborator was "National Health and Medical Research Council, Australia" with 2 trials as a collaborator, "Arbeitsgemeinschaft fur Internistische Onkologie" with 1 trials as a collaborator, "Dutch Colorectal Cancer Group (DCCG)" with 1 trials as a collaborator, "EORTC GI Group (EORTC 40023)" with 1 trials as a collaborator and "Egyptian Foundation For Cancer Research" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Karl-Franzens-University Graz" are "Cystic Fibrosis" (3 trials), "Liver Cirrhosis, Biliary" (2 trials), "Lymphoma" (2 trials), "Ovarian Cancer" (2 trials) and "Sarcoma" (2 trials). Many other conditions were trialed in "Karl-Franzens-University Graz" in a lesser frequency.

Most popular intervention types in "Karl-Franzens-University Graz" are "Drug" (16 trials), "Procedure" (9 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "IVA" (3 trials), "adjuvant therapy" (3 trials), "conventional surgery" (3 trials) and "cisplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Karl-Franzens-University Graz" are 18 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Karl-Franzens-University Graz". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Karl-Franzens-University Graz, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Karl-Franzens-University Graz, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".